Harriet Robinson
#181,257
Most Influential Person Across History
Researcher
Harriet Robinson's AcademicInfluence.com Rankings
Download Badge
Philosophy Biology
Harriet Robinson's Degrees
- PhD Immunology University of California, San Francisco
- Doctorate Medicine University of California, San Francisco
Why Is Harriet Robinson Influential?
(Suggest an Edit or Addition)According to Wikipedia, Harriet Latham Robinson is an American vaccine researcher who is founder and Chief Scientific Officer Emeritus at GeoVax. She is the former Chief of Microbiology and Immunology at the Yerkes National Primate Research Center and Asa Griggs Candler Professor of Microbiology at Emory University. Her research considered HIV vaccine development. She is a Fellow of the American Association for the Advancement of Science.
Harriet Robinson's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. (1993) (1150)
- Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA Vaccine (2001) (753)
- Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. (2002) (672)
- Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. (1997) (593)
- Avian leukosis virus-induced tumors have common proviral integration sites and synthesize discrete new RNAs: oncogenesis by promoter insertion (1981) (469)
- Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations (1999) (409)
- Multiple-Cytokine-Producing Antiviral CD4 T Cells Are Functionally Superior to Single-Cytokine-Producing Cells (2007) (314)
- Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations. (1997) (302)
- The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites. (1997) (268)
- Knowledge Management in UK Construction: Strategies, Resources and Barriers (2004) (251)
- T cell vaccines for microbial infections (2005) (232)
- C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge (2000) (229)
- STEPS: a knowledge management maturity roadmap for corporate sustainability (2006) (212)
- Acceptor sites for retroviral integrations map near DNase I-hypersensitive sites in chromatin (1986) (203)
- Route and Method of Delivery of DNA Vaccine Influence Immune Responses in Mice and Non-Human Primates (1999) (187)
- Knowledge management practices in large construction organisations (2005) (166)
- Critical Role for Env as well as Gag-Pol in Control of a Simian-Human Immunodeficiency Virus 89.6P Challenge by a DNA Prime/Recombinant Modified Vaccinia Virus Ankara Vaccine (2002) (166)
- Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin. (1994) (162)
- Phase 1 safety and immunogenicity testing of DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles. (2011) (162)
- Use of DNAs expressing HIV-1 Env and noninfectious HIV-1 particles to raise antibody responses in mice. (1995) (156)
- Human Immunodeficiency Virus Type 1 Controllers but Not Noncontrollers Maintain CD4 T Cells Coexpressing Three Cytokines (2007) (156)
- Host Susceptibility to endogenous viruses: defective, glycoprotein-expressing proviruses interfere with infections (1981) (156)
- Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys (1996) (148)
- Cross-protection among lethal H5N2 influenza viruses induced by DNA vaccine to the hemagglutinin (1997) (144)
- Different Patterns of Immune Responses but Similar Control of a Simian-Human Immunodeficiency Virus 89.6P Mucosal Challenge by Modified Vaccinia Virus Ankara (MVA) and DNA/MVA Vaccines (2002) (139)
- Successful DNA immunization against measles: Neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles (2000) (138)
- Studies of the Neutralizing Activity and Avidity of Anti-Human Immunodeficiency Virus Type 1 Env Antibody Elicited by DNA Priming and Protein Boosting (1998) (134)
- Service delivery and performance monitoring in PFI/PPP projects (2009) (134)
- Use of DNA encoding influenza hemagglutinin as an avian influenza vaccine. (1993) (134)
- Apoptosis-mediated enhancement of DNA-raised immune responses by mutant caspases (2001) (133)
- DNA immunization for influenza virus: studies using hemagglutinin- and nucleoprotein-expressing DNAs. (1997) (124)
- Heterogeneity of genetic loci in chickens: analysis of endogenous viral and nonviral genes by cleavage of DNA with restriction endonucleases (1979) (124)
- DNA vaccines for viral infections: basic studies and applications. (2000) (122)
- Patterns of proviral insertion and deletion in avian leukosis virus-induced lymphomas (1986) (113)
- Proteins of Rous sarcoma virus. (1968) (113)
- Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein. (1995) (113)
- Protection against rotavirus infections by DNA vaccination. (1996) (109)
- The Use of Nonhuman Primate Models in HIV Vaccine Development (2008) (108)
- IMPaKT: A Framework for Linking Knowledge Management to Business Performance (2003) (108)
- Prevention of infection by a granulocyte-macrophage colony-stimulating factor co-expressing DNA/modified vaccinia Ankara simian immunodeficiency virus vaccine. (2011) (105)
- DNA vaccines: a novel approach to immunization. (1995) (100)
- A Knowledge Transfer Framework: the PFI context (2006) (99)
- DNA vaccines: basic mechanism and immune responses (Review). (1999) (98)
- DNA in uninfected and virus-infected cells complementary to avian tumor virus RNA. (1971) (97)
- Accumulation of human immunodeficiency virus type 1 DNA in T cells: results of multiple infection events (1990) (96)
- Immunogenicity of DNA vaccines expressing human immunodeficiency virus type 1 envelope glycoprotein with and without deletions in the V1/2 and V3 regions. (1998) (93)
- A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model (2017) (93)
- At least two regions of the viral genome determine the oncogenic potential of avian leukosis viruses. (1982) (92)
- Enhanced avidity maturation of antibody to human immunodeficiency virus envelope: DNA vaccination with gp120-C3d fusion proteins. (2001) (92)
- Business performance measurement practices in construction engineering organisations (2005) (92)
- Microarray Profiling of Antibody Responses against Simian-Human Immunodeficiency Virus: Postchallenge Convergence of Reactivities Independent of Host Histocompatibility Type and Vaccine Regimen (2003) (91)
- C3d enhancement of neutralizing antibodies to measles hemagglutinin. (2001) (86)
- Adjuvanting a DNA vaccine with a TLR9 ligand plus Flt3 ligand results in enhanced cellular immunity against the simian immunodeficiency virus (2007) (85)
- Isolation and characterization of proteins from Rous sarcoma virus. (1971) (78)
- Antibody-forming cell response to virus challenge in mice immunized with DNA encoding the influenza virus hemagglutinin (1995) (78)
- Review and implementation of performance management models in construction engineering organizations (2005) (78)
- Participation, barriers, and opportunities in PFI: the United Kingdom experience (2008) (77)
- Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles. (2014) (77)
- Simian Immunodeficiency Virus (SIV) Infection of a Rhesus Macaque Induces SIV-Specific CD8+ T Cells with a Defect in Effector Function That Is Reversible on Extended Interleukin-2 Incubation (2001) (77)
- GM-CSF DNA: an adjuvant for higher avidity IgG, rectal IgA, and increased protection against the acute phase of a SHIV-89.6P challenge by a DNA/MVA immunodeficiency virus vaccine. (2007) (77)
- DNA and virus particle vaccination protects against acquisition and confers control of viremia upon heterologous simian immunodeficiency virus challenge (2013) (76)
- Ten genetic loci in the chicken that contain structural genes for endogenous avian leukosis viruses. (1980) (75)
- High-frequency transduction of c-erbB in avian leukosis virus-induced erythroblastosis (1985) (73)
- Preclinical Studies of Human Immunodeficiency Virus/AIDS Vaccines: Inverse Correlation between Avidity of Anti-Env Antibodies and Peak Postchallenge Viremia (2009) (71)
- Role of Methylation in the Induced and Spontaneous Expression of the Avian Endogenous Virus ev-1: DNA Structure and Gene Products (1982) (70)
- Regulation of DNA-Raised Immune Responses by Cotransfected Interferon Regulatory Factors (2002) (70)
- Protective immunity induced by rotavirus DNA vaccines. (1997) (70)
- DNA Vaccines for Influenza Virus: Differential Effects of Maternal Antibody on Immune Responses to Hemagglutinin and Nucleoprotein (2000) (69)
- Induction of Neutralizing Antibodies and Gag-Specific Cellular Immune Responses to an R5 Primary Isolate of Human Immunodeficiency Virus Type 1 in Rhesus Macaques (2001) (69)
- Attenuated Salmonella enterica Serovar Typhi and Shigella flexneri 2a Strains Mucosally Deliver DNA Vaccines Encoding Measles Virus Hemagglutinin, Inducing Specific Immune Responses and Protection in Cotton Rats (2003) (68)
- Screening of HIV-1 Env glycoproteins for the ability to raise neutralizing antibody using DNA immunization and recombinant vaccinia virus boosting. (1997) (67)
- Vaccines: New hope for an aids vaccine (2002) (67)
- DNA Vaccines, Combining Form of Antigen and Method of Delivery to Raise a Spectrum of IFN-γ and IL-4-Producing CD4+ and CD8+ T Cells1 (2003) (67)
- Immunization of the Female Genital Tract with a DNA-Based Vaccine (1998) (66)
- Impact of glycosylation on the immunogenicity of a DNA-based influenza H5 HA vaccine. (2003) (66)
- SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses. (2012) (65)
- Inheritance and expression of chicken genes that are related to avian leukosis sarcoma virus genes. (1978) (65)
- Developing a business case for knowledge management: the IMPaKT approach (2004) (65)
- Multiprotein HIV type 1 clade B DNA/MVA vaccine: construction, safety, and immunogenicity in Macaques. (2004) (64)
- Subgroup-E avian-leukosis-virus-associated disease in chickens. (1980) (63)
- Human immunodeficiency virus type 1 NL4-3 replication in four T-cell lines: rate and efficiency of entry, a major determinant of permissiveness (1991) (63)
- DNA polymerase in defective Rous sarcoma virus. (1971) (60)
- Infrastructure for the Built Environment: Global Procurement Strategies (2005) (59)
- DNA/MVA vaccine for HIV type 1: effects of codon-optimization and the expression of aggregates or virus-like particles on the immunogenicity of the DNA prime. (2004) (59)
- Generation of a consensus sequence from prevalent and incident HIV-1 infections in West Africa to guide AIDS vaccine development. (2002) (58)
- VARIATION IN AVIAN RETROVIRUS GENOMES * (1980) (57)
- Studies on GM-CSF DNA as an adjuvant for neutralizing Ab elicited by a DNA/MVA immunodeficiency virus vaccine. (2006) (56)
- Retrovirus-expressed hemagglutinin protects against lethal influenza virus infections (1988) (56)
- HIV/AIDS Vaccines: 2007 (2007) (54)
- Emerging prospects for the disease-modifying treatment of Alzheimer's disease. (2005) (52)
- Studies on antibody responses following neonatal immunization with influenza hemagglutinin DNA or protein. (1999) (51)
- Recombinant modified vaccinia virus Ankara provides durable protection against disease caused by an immunodeficiency virus as well as long-term immunity to an orthopoxvirus in a non-human primate. (2007) (51)
- CD40L-Adjuvanted DNA/Modified Vaccinia Virus Ankara Simian Immunodeficiency Virus SIV239 Vaccine Enhances SIV-Specific Humoral and Cellular Immunity and Improves Protection against a Heterologous SIVE660 Mucosal Challenge (2014) (50)
- Expression of endogenous ALV antigens and susceptibility to subgroup E ALV in three strains of chickens (endogenous avian C-type virus). (1976) (50)
- Selenodiglutathione is a highly efficient oxidant of reduced thioredoxin and a substrate for mammalian thioredoxin reductase (2001) (49)
- Intracellular restriction on the growth of induced subgroup E avian type C viruses in chicken cells (1976) (49)
- HIV-1 DNA/MVA vaccination reduces the per exposure probability of infection during repeated mucosal SHIV challenges. (2006) (49)
- Isolation of noninfectious particles containing Rous sarcoma virus RNA from the medium of Rous sarcoma virus-transformed nonproducer cells. (1967) (49)
- Excellent safety and tolerability of the human immunodeficiency virus type 1 pGA2/JS2 plasmid DNA priming vector vaccine in HIV type 1 uninfected adults. (2006) (49)
- Differences in sequences encoding the carboxyl-terminal domain of the epidermal growth factor receptor correlate with differences in the disease potential of viral erbB genes. (1986) (49)
- Genomes of endogenous and exogenous avian retroviruses. (1983) (48)
- Tumor virus RNA's. (1967) (48)
- Correlation of immunogenicities and in vitro expression levels of recombinant modified vaccinia virus Ankara HIV vaccines. (2008) (47)
- DNA immunization: effect of secretion of DNA-expressed hemagglutinins on antibody responses. (1999) (47)
- Multiprotein HIV type 1 clade B DNA and MVA vaccines: construction, expression, and immunogenicity in rodents of the MVA component. (2004) (47)
- Production of unique C-type viruses by chicken cells grown in bromodeoxyuridine. (1976) (47)
- Influence of env and long terminal repeat sequences on the tissue tropism of avian leukosis viruses (1988) (45)
- Studies using a viral challenge and CD8 T cell depletions on the roles of cellular and humoral immunity in the control of an SHIV-89.6P challenge in DNA/MVA-vaccinated macaques. (2005) (44)
- Mucosal immunization with DNA encoding influenza hemagglutinin. (1997) (44)
- Avian leukosis virus-induced osteopetrosis is associated with the persistent synthesis of viral DNA. (1985) (44)
- Non-neutralizing antibodies in prevention of HIV infection (2013) (43)
- Basic mechanisms of DNA-raised antibody responses to intramuscular and gene gun immunizations. (2000) (42)
- Dsi-1, a region with frequent proviral insertions in Moloney murine leukemia virus-induced rat thymomas (1987) (42)
- DNA/MVA HIV-1/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge (2007) (42)
- Long terminal repeat (LTR) sequences, env, and a region near the 5' LTR influence the pathogenic potential of recombinants between Rous-associated virus types 0 and 1 (1988) (39)
- Preexisting Vaccinia Virus Immunity Decreases SIV-Specific Cellular Immunity but Does Not Diminish Humoral Immunity and Efficacy of a DNA/MVA Vaccine (2010) (39)
- Gs, an allele of chickens for endogenous avian leukosis viral antigens, segregates with ev 3, a genetic locus that contains structural genes for virus (1979) (38)
- Signature for Long-Term Vaccine-Mediated Control of a Simian and Human Immunodeficiency Virus 89.6P Challenge: Stable Low-Breadth and Low-Frequency T-Cell Response Capable of Coproducing Gamma Interferon and Interleukin-2 (2005) (37)
- A Single Dose of Modified Vaccinia Ankara expressing Ebola Virus Like Particles Protects Nonhuman Primates from Lethal Ebola Virus Challenge (2018) (36)
- DNA prime/protein boost vaccine strategy in neonatal macaques against simian human immunodeficiency virus (2002) (35)
- Th1 genetic adjuvants modulate immune responses in neonates. (2001) (35)
- Governance and Knowledge Management for Public-Private Partnerships (2010) (35)
- Early studies on DNA-based immunizations for measles virus. (1997) (35)
- A modular gene targeting system for sequential transgene stacking in plants. (2015) (34)
- Assessment of retrovirus-expressed nucleoprotein as a vaccine against lethal influenza virus infections of chickens. (1992) (33)
- A new generation of HIV vaccines. (2002) (33)
- Tools and Techniques for Knowledge Management (2008) (32)
- Role of different lymphoid tissues in the initiation and maintenance of DNA-raised antibody responses to the influenza virus H1 glycoprotein (1996) (32)
- Immunogenicity in Macaques of the Clinical Product for a Clade B DNA/MVA HIV Vaccine: Elicitation of IFN-γ, IL-2, and TNF-α Coproducing CD4 and CD8 T Cells (2007) (31)
- Induction of angiosarcoma by a c-erbB transducing virus (1985) (31)
- Breakthrough of SIV strain smE660 challenge in SIV strain mac239-vaccinated rhesus macaques despite potent autologous neutralizing antibody responses (2015) (31)
- Prime boost vaccines power up in people (2003) (31)
- Replication of patient isolates of human immunodeficiency virus type 1 in T cells: a spectrum of rates and efficiencies of entry. (1992) (30)
- Gp120-alum boosting of a Gag-Pol-Env DNA/MVA AIDS vaccine: poorer control of a pathogenic viral challenge. (2003) (30)
- Shots in the Dark: The Wayward Search for an AIDS Vaccine (2001) (30)
- Identification of a mouse protein homologous to the human CD6 T cell surface protein and sequence of the corresponding cDNA. (1995) (30)
- Inhibition of growth of uninfected and rous sarcoma virus-infected chick-embryo fibroblasts by rifampicin. (1971) (29)
- Erratum: Successful DNA immunization against measles: Neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles (Nature Medicine (2000) 6 (776-781)) (2000) (29)
- The Scientific Future of DNA for Immunization (1997) (28)
- Replication of Rous sarcoma virus in synchronized cells. (1970) (28)
- Endogenous virus expression in chicken lines maintained at the Regional Poultry Research Laboratory. (1979) (28)
- Human immunodeficiency virus type 1 entry into T cells: more-rapid escape from an anti-V3 loop than from an antireceptor antibody (1992) (28)
- Control of a Mucosal Challenge and Prevention of AIDS in Rhesus Macaques by a Multiprotein DNA/MVA Vaccine (2001) (28)
- Different patterns of expansion, contraction and memory differentiation of HIV-1 Gag-specific CD8 T cells elicited by adenovirus type 5 and modified vaccinia Ankara vaccines. (2011) (28)
- HIV/AIDS Vaccines: 2018 (2018) (27)
- A Combination DNA and Attenuated Simian Immunodeficiency Virus Vaccine Strategy Provides Enhanced Protection from Simian/Human Immunodeficiency Virus-Induced Disease (2005) (27)
- Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults (2017) (26)
- Impact of governance on project delivery of complex NHS PFI/PPP schemes (2010) (26)
- Comparative immunogenicity in rhesus monkeys of multi-protein HIV-1 (CRF02_AG) DNA/MVA vaccines expressing mature and immature VLPs. (2005) (26)
- New findings on the congenital transmission of avian leukosis viruses. (1984) (26)
- Slowly Declining Levels of Viral RNA and DNA in DNA/Recombinant Modified Vaccinia Virus Ankara-Vaccinated Macaques with Controlled Simian-Human Immunodeficiency Virus SHIV-89.6P Challenges (2002) (25)
- Increased oncogenic potential of ErbB is associated with the loss of a COOH-terminal domain serine phosphorylation site. (1992) (25)
- Comparative studies on in vitro expression and in vivo immunogenicity of supercoiled and open circular forms of plasmid DNA vaccines. (2008) (25)
- Context-dependent role of human immunodeficiency virus type 1 auxiliary genes in the establishment of chronic virus producers (1993) (25)
- Sequences in the gag-pol-5'env region of avian leukosis viruses confer the ability to induce osteopetrosis. (1985) (25)
- HIV-1 Env glycoproteins from two series of primary isolates: replication phenotype and immunogenicity. (1997) (25)
- DNA/MVA Vaccination of HIV-1 Infected Participants with Viral Suppression on Antiretroviral Therapy, followed by Treatment Interruption: Elicitation of Immune Responses without Control of Re-Emergent Virus (2016) (25)
- Neutralizing antibody responses in Africa green monkeys naturally infected with simian immunodeficiency virus (SIVagm) (1999) (24)
- Low freqeuncy production of recombinant subgroup E avian leukosis viruses by uninfected V-15B chicken cells. (1979) (23)
- HIV-1 gp120 and Modified Vaccinia Virus Ankara (MVA) gp140 Boost Immunogens Increase Immunogenicity of a DNA/MVA HIV-1 Vaccine (2017) (22)
- Phase 1 clinical trials of the National Institutes of Health Vaccine Research Center HIV/AIDS candidate vaccines. (2006) (21)
- DNA vaccines: a review of developments. (1997) (20)
- Co-expression of HIV-1 virus-like particles and granulocyte-macrophage colony stimulating factor by GEO-D03 DNA vaccine (2012) (20)
- Immunogenicity in macaques of the clinical product for a clade B DNA/MVA HIV vaccine: elicitation of IFN-gamma, IL-2, and TNF-alpha coproducing CD4 and CD8 T cells. (2007) (20)
- Dose-response studies for the elicitation of CD8 T cells by a DNA vaccine, used alone or as the prime for a modified vaccinia Ankara boost. (2007) (20)
- Sequences near the 5' long terminal repeat of avian leukosis viruses determine the ability to induce osteopetrosis (1986) (20)
- Studies on the cross-clade and cross-species conservation of HIV-1 Gag-specific CD8 and CD4 T cell responses elicited by a clade B DNA/MVA vaccine in macaques. (2005) (20)
- Optimization of a multi-gene HIV-1 recombinant subtype CRF02_AG DNA vaccine for expression of multiple immunogenic forms. (2004) (19)
- An investigation into solid waste problem in the Egyptian construction industry: A mini-review (2020) (19)
- V-15B, an allele of chickens for the production of a noninfectious avian leukosis virus. (1979) (18)
- DNA priming and recombinant pox virus boosters for an AIDS vaccine. (2000) (18)
- λ Light Chain Bias Associated With Enhanced Binding and Function of Anti-HIV Env Glycoprotein Antibodies. (2016) (18)
- DNA vaccines against rotavirus infections. (1996) (17)
- SIV DNA vaccine trial in macaques: post-challenge necropsy in vaccine and control groups. (1997) (17)
- Defective IL-2 production by HIV-1-specific CD4 and CD8 T cells in an adolescent/young adult cohort. (2006) (17)
- Proteins of Avian Tumor Viruses with Different Coat Antigens (1970) (17)
- Sequences outside of the long terminal repeat determine the lymphomogenic potential of Rous-associated virus type 1 (1985) (16)
- Strong, but Age-Dependent, Protection Elicited by a Deoxyribonucleic Acid/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine (2016) (16)
- LINKING KNOWLEDGE MANAGEMENT STRATEGY TO BUSINESS PERFORMANCE IN CONSTRUCTION ORGANIZATIONS (2004) (16)
- Retroviruses and cancer. (1982) (15)
- Performance Measurement in Knowledge Management (2008) (14)
- Heterologous neutralizing antibody induction in a simian-human immunodeficiency virus primate model: lack of original antigenic sin. (2001) (14)
- High Doses of GM-CSF Inhibit Antibody Responses in Rectal Secretions and Diminish Modified Vaccinia Ankara/Simian Immunodeficiency Virus Vaccine Protection in TRIM5α-Restrictive Macaques (2016) (14)
- Tissue tropism of avian leukosis viruses: analyses for viral DNA and proteins. (1993) (14)
- Protein tyrosine kinase activities of the epidermal growth factor receptor and ErbB proteins: correlation of oncogenic activation with altered kinetics (1992) (13)
- Novel simian immunodeficiency virus CTL epitopes restricted by MHC class I molecule Mamu-B*01 are highly conserved for long term in DNA/MVA-vaccinated, SHIV-challenged rhesus macaques. (2005) (13)
- DNA Vaccines (1997) (13)
- HIV transmitted/founder vaccines elicit autologous tier 2 neutralizing antibodies for the CD4 binding site (2017) (12)
- DNA Vaccines: Influenza Virus Challenge of a Th2/Tc2 Immune Response Results in a Th2/Tc1 Response in the Lung (2004) (12)
- The immune space: a concept and template for rationalizing vaccine development. (2014) (12)
- Effect of CpG methylation on isotype and magnitude of antibody responses to influenza hemagglutinin-expressing plasmid. (1999) (12)
- The Construction, Building and Real Estate Research Conference of the Royal Institution of Chartered Surveyors Held at Dauphine Université, Paris, 2-3 September 2010 (2010) (11)
- Expansion and Exhaustion of T-Cell Responses during Mutational Escape from Long-Term Viral Control in Two DNA/Modified Vaccinia Virus Ankara-Vaccinated and Simian-Human Immunodeficiency Virus SHIV-89.6P-Challenged Macaques (2008) (11)
- Role of RAV-0 genes in the permissive replication of subgroup E avian leukosis viruses on line 15Bev1 CEF. (1988) (10)
- Nucleic Acid Immunizations (1998) (10)
- Block of long-term potentiation by intracellular application of anti-phosphatidylinositol 4,5-bisphosphate antibody in hippocampal pyramidal neurons (1993) (10)
- Studies on in vitro expression and in vivo immunogenicity of a recombinant MVA HIV vaccine. (2006) (10)
- Short Communication: Studies in Macaques on Cross-Clade T Cell Responses Elicited by a DNA/MVA AIDS Vaccine, Better Conservation of CD8 Than CD4 T Cell Responses (2005) (9)
- T cells versus HIV-1: fighting exhaustion as well as escape (2003) (9)
- Poor Immune Responses of Newborn Rhesus Macaques to Measles Virus DNA Vaccines Expressing the Hemagglutinin and Fusion Glycoproteins (2012) (9)
- The Induction of Mucosal Immunity in the Female Genital Tract Using Gene‐Gun Technology Part 1: Antigen Expression (1995) (9)
- A Knowledge Management Framework to Manage Intellectual Capital for Corporate Sustainability (2010) (9)
- 5' avian leukosis virus sequences and osteopetrotic potential. (1992) (9)
- Infrequent involvement of c-fos in avian leukosis virus-induced nephroblastoma (1990) (9)
- Susceptibility to erbB-induced erythroblastosis is a dominant trait of 151 chickens (1985) (8)
- Local Control of Repeated-Dose Rectal Challenges in DNA/MVA-Vaccinated Macaques Protected against a First Series of Simian Immunodeficiency Virus Challenges (2014) (8)
- Impact of vaccine type on HIV-1 vaccine elicited antibody durability and B cell gene signature (2020) (7)
- CD 40 L-Adjuvanted DNA / Modified Vaccinia Virus Ankara Simian Immunodeficiency Virus SIV 239 Vaccine Enhances SIV-Specific Humoral and Cellular Immunity and Improves Protection against a Heterologous SIVE 660 Mucosal Challenge (7)
- Design Economics for the Built Environment Impact of Sustainability on Project Evaluation (2015) (7)
- Investigating current practices, participation and opportunities in private finance initiative, technical report (2004) (7)
- One Group's Historical Reflections on DNA Vaccine Development (2018) (6)
- Replication of an osteopetrosis-inducing avian leukosis virus in fibroblasts, osteoblasts, and osteopetrotic bone. (1994) (6)
- Working towards an HIV/AIDS vaccine (2009) (6)
- Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humans (2021) (6)
- Absence of SHIV infection in gut and lymph node tissues in rhesus monkeys after repeated rectal challenges following HIV-1 DNA/MVA immunizations. (2007) (6)
- Mining the mechanisms of an HIV vaccine (2012) (5)
- The impact of infrastructure investment on economic growth in the United Kingdom (2020) (5)
- Knowledge Management Strategies: Learning from Other Sectors (2003) (5)
- Studies in macaques on cross-clade T cell responses elicited by a DNA/MVA AIDS vaccine, better conservation of CD8 than CD4 T cell responses. (2005) (4)
- IMPROVING STRUCTURAL DESIGN PROCESSES THROUGH KNOWLEDGE MANAGEMENT (2002) (4)
- Endogenous retroviruses of mice and chickens. (1982) (4)
- The replication of subgroup E avian retroviruses is blocked at or before viral DNA synthesis in restrictive chicken cells. (1979) (4)
- DNA Vaccines for Mucosal Immunity to Infectious Diseases (2005) (4)
- RELATIONSHIP AND KNOWLEDGE MANAGEMENT AMONG CONSTRUCTION DEVELOPMENT PROJECT MEMBERS IN THAILAND: THE CLIENTS' PERSPECTIVE (2008) (4)
- Protective immunity from a germinal center sanctuary (2012) (4)
- Induction of renal adenocarcinoma by a nonmutated erbB oncogene (1993) (3)
- Influence of avian leukosis viral sequences on transmission to the egg and embryo. (1989) (3)
- Outreach and the evolution of critical care (2010) (3)
- Making public private partnerships effective for infrastructure projects: role of governance and knowledge transfer (2011) (3)
- Genetic control of endogenous avian tumor virus expression. (1976) (3)
- Viral attenuation by design (2008) (3)
- The Scientific Future of DNA for Immunization American Academy of Microbiology (1997) (3)
- Theories and Principles of Design Economics (2015) (2)
- Avian leukosis viruses and cancer: genetics of insertional mutagenesis. (1983) (2)
- Avian lymphoid leukosis is correlated with the appearance of discrete new RNAs containing viral and cellular genetic information. (1981) (2)
- Murine retroviral vectors: T-cell line specific expression of a cytomegalovirus immediate early promoter. (1990) (2)
- Development of a Zika vaccine using a novel MVA-VLP platform (2016) (2)
- A skilled manager, strategic to real estate financing (2018) (2)
- The Payment Mechanism in Operational PFI Projects (2009) (2)
- English Shakesperian criticism : in the eighteenth century (1932) (2)
- Good Ethics and Bad Choices: The Relevance of Behavioral Economics for Medical Ethics (2022) (2)
- Associations Between Serum Sodium Concentration and Bone Health Measures in Individuals Who Use Antiepileptic Drugs: A Pilot Study. (2019) (2)
- Cancer induction by insertional mutagenesis: the role of viral genes in avian leukosis virus induced cancers. (1983) (2)
- Re-using knowledge and leveraging technology to reduce project design and construction costs, in Design Economics for the Built Environment (2015) (2)
- The genetic basis of retroviral-induced transformation. (1982) (2)
- Exploiting Automated Technologies for Reduction of Rework in Construction Housing Supply Chain (2019) (2)
- Ebola virus – prospects for a novel virus-like-particle-expressing modified vaccinia Ankara-based vaccine (2018) (1)
- Genetics of leukemogenesis by avian leukosis viruses. (1981) (1)
- Corporate governance and investment decision-making in real estate investment trusts (REITs) (2018) (1)
- AIDSVAX protein boost improves breadth and magnitude of vaccine-induced HIV-1 envelope-specific responses after a 7-year rest period. (2021) (1)
- Distinct HIV-Specific Antibody Fc-Profiles in RV144 and VAX003 Vaccinees (2013) (1)
- Minoan Bee Smokers:: An Experimental Approach (2012) (1)
- Abortion on the Basis of a Risk of Disability (2019) (1)
- A Single Dose of Modified Vaccinia Ankara expressing Ebola Virus Like Particles Protects Nonhuman Primates from Lethal Ebola Virus Challenge (2018) (1)
- Editorial overview: Preventive and therapeutic vaccines. (2016) (1)
- Preschool developmental screening--testing the feasibility of flexible implementation of a standard programme. (1984) (1)
- A Model to Assess the Accuracy of Detecting Arboviruses in Mosquito Pools (2009) (1)
- Establishment of interference in osteoblasts by an osteopetrosis-inducing avian leukosis virus. (1994) (1)
- Effect of pulmonary rehabilitation on dyspnea and exercise tolerance in patients with interstitial lung disease: a systematic review (2022) (0)
- Autoantigen in Multiple Sclerosis Responsible for Its Incorrect Assignment as an B-Crystallin Is α Chaperone Activity of (2011) (0)
- A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model (2017) (0)
- A knowledge transfer framework: the construction context (2005) (0)
- Mva expressing envelope genes, gag and pol HIV modified. (2002) (0)
- VIRAL ENVELOPE GENES AND c REGIONS IN NON-ACUTE AVIAN LEUKOSIS VIRUS ASSOCIATED DISEASE (1980) (0)
- Multiprotein DNA / MVA Vaccine Control of a Mucosal Challenge and Prevention of AIDS by a (2011) (0)
- Speci fi city and 6-Month Durability of Immune Responses Induced by DNA and Recombinant Modi fi ed Vaccinia Ankara Vaccines Expressing HIV-1 Virus-Like Particles (2014) (0)
- Ethical Predisposition of Project Managers in the Delivery of Construction Projects in the NHS (2018) (0)
- Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humans (2021) (0)
- measles virus DNA vaccines expressing the hemagglutinin and (2012) (0)
- 124 GeoVax HIV/AIDS Vaccine Program, Preclinical and Clinical Studies (2012) (0)
- Recombinant MVA viruses expressing MODIFIED env, gag and pol genes of HIV CLADE A / G, CLADE CLADE B AND C (2005) (0)
- 24. Case Studies (2015) (0)
- 140 Induction of Efficacious Immune Responses Using Heterologous Prime: Boost Regimens of Recombinant DNA and MVA Vectored HIV Vaccines and GM-CSF as the Adjuvant (2011) (0)
- Mutation of the Doughnut Locus Leads to Rod and Cone Dystrophy and Vestibular Defects in Zebrafish (2010) (0)
- Clade B virus-like particle (VLP)-expressing HIV vaccine (2014) (0)
- At least two regions of the viral ger potential of avian leukosis viruses (in vivo oncogenicity test/leukemogenic potential/osteopetrotic poten (2016) (0)
- Encompassing Infection-Specific Epitopes Gives Long-Lasting T Cell Immunity Natural Exposure to Cutaneous Anthrax (2010) (0)
- and Efficacy of a DNA/MVA Vaccine but Does Not Diminish Humoral Immunity Decreases SIV-Specific Cellular Immunity Preexisting Vaccinia Virus Immunity (2010) (0)
- Team Relationship and Knowledge Management in Construction Projects in Thailand Part 1: Network Relationship Analysis Using UCINET Software (2018) (0)
- Chapter 2 Theories and Principles of Design Economics (2018) (0)
- CORRESPONDENCE. PORTLAND CEMENT AND THE QUESTION OF ITS AERATION. (0)
- Jonas‐SébastienBeaudry, The Disabled Contract: Severe Intellectual Disability, Justice and Morality, Cambridge: Cambridge University Press, 2021, xix + 314 pp, hb £85.00 (2022) (0)
- Improving hip fracture rehabilitation against CSP standards using an integrated physiotherapy and occupational therapy team approach (2021) (0)
- Reusing knowledge and leveraging technology to reduce design and construction costs (2015) (0)
- Appraisal of Design to Determine Viability of Development Schemes (2015) (0)
- Chapter 15 Re-using knowledge and leveraging technology to reduce project duration , design and construction costs (2018) (0)
- Sequences Outside oftheLongTerminal RepeatDetermine the Lymphomogenic Potential ofRous-Associated VirusType1 (1985) (0)
- Te Deum Laudamus and Benedictus in D (1898) (0)
- Clinicopathologic and genomic characterizations of brain metastases using a comprehensive genomic panel (2022) (0)
- Original Articles RouteandMethodofDelivery ofDNA Vaccine Influence Immune ResponsesinMiceandNon- Human Primates (1999) (0)
- Prenatal testing, disability equality, and the limits of the law. (2022) (0)
- Economic Context, Policy Environment and the Changing Role of Design Economists (2015) (0)
- Sustainable Design, Innovation and Competitiveness in Construction Firms (2015) (0)
- Achieving Zero Carbon in Sustainable Communities (2015) (0)
- New Approaches and Rules of Measurement for Cost Estimating and Planning (2015) (0)
- Relationship and Knowledge Management in Construction Projects in Thailand Part 2: The Studies of Knowledge Management Process and the Three-stage Project Development Performance Improvement Framework (2022) (0)
This paper list is powered by the following services:
Other Resources About Harriet Robinson
What Schools Are Affiliated With Harriet Robinson?
Harriet Robinson is affiliated with the following schools:
